European Medicines Agency Recommends Adding “Heavy Menstrual Bleeding” to Pfizer and Moderna’s COVID Shots Product Information as a Side Effect

By Jim Hoft Published October 28, 2022  TGP

On Friday, the European Medicines Agency (EMA) recommended adding “heavy menstrual bleeding” to the list of side effects caused by Pfizer and Moderna’s mRNA shots.

In April 2021, The Gateway Pundit first reported on the tens of thousands of women who complained about irregular menstruation after taking the COVID vaccines.

Women who received the Covid vaccine reported to have spotting in between their cycles, shortened cycles, and lengthened cycles.

However, anyone who spoke about a link between Covid vaccines and menstrual problems/fertility issues was labeled a “conspiracy theorist.”

Earlier this year, the EMA’s risk assessment committee announced that it would review reports of menstruation irregularities after thousands of women reported changes to their monthly cycle after getting the COVID vaccine.

“After reviewing the available evidence, the PRAC decided to request an in-depth evaluation of all available data, including reports from spontaneous reporting systems, clinical trials, and the published literature,” according to the news release.

“At this stage, it is not yet clear whether there is a causal link between the COVID-19 vaccines and the reports of heavy periods or amenorrhea. There is also no evidence to suggest that COVID-19 vaccines affect fertility,” the agency said.

Now, the regulatory body recommended including “heavy menstrual bleeding” as an adverse effect on the list of product warnings and precautions.

Read the EMA statement:

The PRAC has recommended that heavy menstrual bleeding should be added to the product information as a side effect of unknown frequency of the mRNA COVID-19 vaccines Comirnaty and Spikevax.

Heavy menstrual bleeding (heavy periods) may be defined as bleeding characterised by an increased volume and/or duration which interferes with the person’s physical, social, emotional and material quality of life. Cases of heavy menstrual bleeding have been reported after the first, second and booster doses of Comirnaty and Spikevax.

The PRAC finalised the assessment of this safety signal after reviewing the available data, including cases reported during clinical trials, cases spontaneously reported in Eudravigilance and findings from the medical literature.

After reviewing the data, the Committee concluded that there is at least a reasonable possibility that the occurrence of heavy menstrual bleeding is causally associated with these vaccines and therefore recommended the update of the product information.

The available data reviewed involved mostly cases which appeared to be non-serious and temporary in nature.

Menstrual disorders in general are quite common and they can occur for a wide range of reasons. This includes some underlying medical conditions. Any person who experiences postmenopausal bleeding or is concerned about a change in menstruation should consult their doctor.

There is no evidence to suggest the menstrual disorders experienced by some people have any impact on reproduction and fertility. Available data provides reassurance about the use of mRNA COVID-19 vaccines before and during pregnancy. A review carried out by EMA’s Emergency Task Force showed that mRNA COVID-19 vaccines do not cause pregnancy complications for expectant mothers and their babies, and they are as effective at reducing the risk of hospitalisation and deaths in pregnant people as they are in non-pregnant people.

The Committee reiterates that the totality of data available confirms that the benefits of these vaccines greatly outweigh the risks.

Healthcare professionals and patients are encouraged to continue to report cases of heavy menstrual bleeding to their national authorities.

The PRAC will continue to monitor for cases of this condition and will communicate further if new recommendations are warranted.

Psoriasis and COVID-19 Vaccine: What to Know

Authors: Christine Zink, MD  Updated on October 19, 2022 Medically reviewed by Casey Gallagher, MD Very Well Health Oct 19, 2022

Psoriasis is a skin disorder characterized by thick, inflamed patches with silvery scales. It is a complex autoimmune and inflammatory disorder in which immune cells inappropriately attack the skin cells, leading to rapid replacement and buildup.1

Psoriasis treatment depends on the disease severity. Sometimes, people with psoriasis and associated arthritis need to take medications to suppress the immune system. These medications can put people at risk for other diseases, including COVID-19. This immunosuppression underscores why it’s essential for people with psoriasis to obtain COVID-19 vaccination, which is safe for people with psoriasis.

This article discusses the benefits, risks, and complications of COVID-19 vaccination in people with psoriasis.

Psoriasis and COVID-19 Risks

According to the National Psoriasis Foundation COVID-19 Task Force, existing evidence suggests that people with psoriasis and psoriatic arthritis—a type of arthritis linked to psoriasis—have the same likelihood of contracting the SARS-CoV-2 infection as the general population.2

The likelihood of a poor outcome from a COVID-19 infection is mainly due to age and other co-occurring conditions like:2

Experts are currently unsure if treatments for psoriasis and psoriatic arthritis change a person’s risk of contracting SARS-CoV-2 or having a worse outcome from COVID-19.2

Healthcare providers agree that patients with psoriasis and COVID-19 should continue their current therapies. Should a person with psoriasis taking immunosuppressive therapies develop COVID-19, they should discuss stopping psoriasis treatment with their healthcare provider.

Preventing COVID-19 and Worsening Psoriasis

The best way to prevent COVID-19 is to wear a mask, wash your hands, and avoid crowded indoor areas. Since people with psoriasis can develop worsening skin lesions with frequent handwashing, dermatologists recommend washing with moisturizing soaps and avoiding alcohol-based sanitizers.3

People with psoriasis and psoriatic arthritis have several different immunosuppressive treatment options. These treatments can put people at risk for other infections, but it seems that experts are less concerned about poor COVID-19 outcomes in people who take targeted immunosuppressive biologic drugs.

Instead, the more concerning immunosuppressants include:4

Experts also recommend avoiding using systemic corticosteroids (those that affect the entire body) to manage psoriatic arthritis when a person has COVID-19.2 The use of corticosteroids during acute infection with SARS-CoV-2 may be associated with worse outcomes. Still, corticosteroids are also used to improve COVID-19 outcomes in hospitalized patients.2

Patients should speak with their healthcare provider about the best course of action for their disease state and COVID-19.

Are COVID-19 Vaccines Safe for People With Psoriasis?

Experts agree that COVID-19 vaccination is safe for all people, including people with psoriasis.5 This includes people who take immunosuppressive therapy for their disease.

Live vaccines can be troublesome for people with chronic illnesses that require immunosuppressive therapy, but none of the COVID-19 vaccines are live vaccines. People who receive vaccination do not develop the disease.

Even though the clinical trials for these vaccines did not include patients on immunosuppressive therapy for conditions like psoriasis, experts agree that these vaccines are still safe.5

Contraindications to COVID-19 Vaccination

The only contraindication (a reason not to take a specific course of action due to possible harm) to COVID-19 vaccination is an allergy to the first dose of vaccine or a component in the vaccine. The only component that could be of concern is polyethylene glycol, which is used as a stabilizer and emulsifier to help keep ingredients in the liquid vaccine mixed.6

Psoriasis and COVID-19 Vaccine Complications

Psoriasis is a lifelong illness that fluctuates in intensity. Acute exacerbations—also called flares or flare-ups—can be caused by new medications, an infection, stress, physical trauma, and possibly vaccination.7

A recent report shows that COVID-19 vaccination can also lead to a psoriasis flare.7 The worsening skin symptoms typically occurred 10 days after vaccination, and they usually happened after the first dose of a two-shot series. In the study, almost no one developed worsening psoriasis after receiving the second dose of vaccine.7

Other vaccines have caused psoriasis flares in people with the disease. Culprit vaccines include:7

  • Influenza (the flu)
  • Tetanus-diphtheria  (prevents illnesses from the Clostridium tetani and Corynebacterium diphtheriae bacteria)
  • Pneumococcal (prevents diseases caused by the Spretococcus pneumoniae bacterium)

The exact reason for a psoriasis flare after COVID-19 vaccination is unclear. No single COVID-19 vaccine is more likely to lead to an exacerbation than another. The good news is that patients have a rapid resolution of the skin flare with ongoing disease management.7

This potential side effect is something to consider regarding COVID-19 vaccination. Still, experts recommend complete COVID-19 vaccination for all patients with psoriasis, despite their autoimmune disease severity and current medication regimen. This recommendation is based on the effectiveness of the COVID-19 vaccines in preventing severe infection and death, which is a worse outcome than a psoriasis flare.7

Most people who develop psoriasis flare-ups after vaccination do so after the first shot, but not the second shot.7

COVID-19 Also Worsens Psoriasis

It’s important to remember that infection with COVID-19 can also lead to psoriasis exacerbation.7

Are COVID-19 Vaccines Effective in People With Psoriasis?

Experts agree that COVID-19 vaccination is not only safe but highly effective for all people, including people with psoriasis.5

The most important thing to remember is that all four vaccines are highly effective at preventing hospitalization and death.8

However, people with psoriasis might be taking immunosuppressive agents to control their disease. People who take these medicines were not included in the vaccine clinical trials.

Immunosuppressive agents prevent an effective immune response with vaccination. Experts suspect that the vaccines might not be as effective in people on immunosuppressive therapies, but they still recommend vaccination.5 

Continuing Taking Your Medications

People with psoriasis should continue their current biologic or immunosuppressive therapy when they are vaccinated. The only exception is in people age 60 and older who take methotrexate. This group should discuss whether to hold their medication with their healthcare provider.4

Although research studies have not been conducted, experts think that a person’s ability to develop immunity probably depends on the specific immunosuppressive agent being taken.5

For instance, patients who take methotrexate have a harder time building immunity with other vaccines, like influenza and pneumococcal, whereas people who take tumor necrosis factor-alpha inhibitors develop strong immunity with vaccination.5

Overall, experts recommend complete vaccination for people with psoriasis. Some immunity is better than none.

Which Vaccine to Get?

The Food and Drug Administration (FDA) has fully approved or granted emergency use authorization (EUA) to four COVID-19 vaccines in the United States:9

Due to possible side effects from the J&J COVID-19 vaccine, the Centers for Disease Control and Prevention (CDC) recommends that people seek one of the mRNA vaccines (Moderna or Pfizer) or the Novavax vaccine over the J&J vaccine.10 

People with psoriatic disease who take immunosuppressive or immune-modulating therapies are eligible for an additional dose of an mRNA vaccine 28 days after the completing the primary series.11 This is different from a booster shot. This third dose is offered to people who have difficulty building immunity because of their underlying disease or medications. 

People who are moderately or severely immunocompromised from their medication should consider getting this additional dose. Speak with your healthcare provider about this recommendation if you have additional risk factors for doing poorly with COVID-19 and are taking:4

  • Orencia (abatacept)
  • Sandimmune (cyclosporine)
  • Arava (leflunomide)
  • Trexall (methotrexate)
  • Xeljanz (tofacitinib)
  • Rinvoq (upadacitinib)
  • Glucocorticoids (e.g., prednisone)

The FDA recently granted EUAs for updated bivalent boosters of the Moderna and Pfizer COVID-19 vaccines.

Bivalent boosters have replaced all previous monovalent booster doses. Anyone who received a monovalent booster should also receive one bivalent booster two months after the second dose or last booster. 

The CDC recommends everyone 5 years and older get an updated bivalent booster. Children ages 5 years are only eligible to receive the bivalent Pfizer booster. Everyone ages 6 years and older can choose to get the Pfizer or Moderna bivalent booster.12

Summary

Psoriasis is a chronic autoimmune and inflammatory skin disorder that is often treated with immunosuppressive therapy. Healthcare providers have concerns that people on these medications are at higher risk of contracting and doing poorly with COVID-19.

Therefore, it is crucial to complete COVID-19 vaccination. The vaccines are safe and effective in people with psoriasis, and experts recommend complete immunization for all people. There is a chance that a person will develop a psoriasis flare as a result of the vaccine, but this is better than a poor outcome from COVID-19.

1 in 780 German Children Under 5 REQUIRES HOSPITALIZATION Due to Severe Adverse Event Following Pfizer’s mRNA COVID shots

BAuthors: Jim Hoft October 20, 2022 JAMA

According to the findings of German research, one in every 700 children under the age of five who received the Pfizer mRNA Covid vaccine was hospitalized with severe adverse events (SAE), and one in every 200 children had ‘symptoms that were currently ongoing and thus of unknown significance.’

The study, “Comparative Safety of the BNT162b2 Messenger RNA COVID-19 Vaccine vs Other Approved Vaccines in Children Younger Than 5 Years,” was published in JAMA on Tuesday, two days before the CDC’s Advisory Committee on Immunization Practices voted to recommend COVID-19 to be included in the 2023 childhood immunization schedule.

Participants in this retrospective cohort study were German parents or caregivers who had enrolled their children in a Covid-19 vaccination program at 21 outpatient care facilities. The survey used in the study was conducted in a secure online environment. From April 14th, 2022, till May 9th, 2022, a total of 19 000 email addresses were contacted using data from vaccine registration databases.

It concluded that the symptoms reported after Pfizer vaccination were “comparable overall” to those for other vaccines. Let’s see.

  • Any symptoms: 62% higher
  • Musculoskeletal (muscles and bones) symptoms: 155% higher
  • Dermatologic (skin) symptoms: 118% higher
  • Otolaryngologic (ears, nose and throat) symptoms: 537% higher
  • Cardiovascular (heart etc.): 36% higher
  • Gastrointestinal (stomach etc.): 54% higher

It calls these “modestly elevated.” (Note that not all are statistically significant and some confidence intervals are wide, see below.)

In 0.5% of the children (40 of 7,806) symptoms were “currently ongoing and thus of unknown significance”. This is in a study with a 2-4 month follow-up period. That means 0.5% of children had an adverse effect that lasted for weeks or months. In two cases (0.03%), symptoms were confirmed to have lasted longer than 90 days.

Ten children were hospitalised with reported serious adverse events (SAEs), compared to zero with the other vaccines. This reported as 0.1%, as it is out of 7,806. However, the study also states that no hospitalisations were reported for children administered the low dosage of 3 μg. Since it also tells us that 6,033 children received at least one dose of over 3 μg (or unknown dosage), the rate in the relevant cohort is closer to 0.2%, or around one in 500.

Four of the hospitalisations were for cardiovascular injury; one child was hospitalised after both doses for this reason. Four were pulmonary (lung) related. Symptoms of the hospitalised children lasted an average of 12.2 days and a maximum of 60 days. None reported a myocarditis diagnosis. Mercifully, no deaths were reported in this relatively small sample.

The mortality rate in under-20s has been shown to be 0.0003%. The figure for under-fives will be even lower. But even if we unrealistically assume this is the mortality rate for under-fives and the vaccines reduce it to zero, this still means that at least 500 children are hospitalised for every life the vaccines save. In reality the ratio will be much worse than this.

On Wednesday, The Gateway Pundit reported that the CDC’s Advisory Committee on Immunization Practices voted to include the COVID-19 vaccine as part of the Vaccines for Children (VFC) Program.

The Vaccines For Children (VFC) program is a federally funded program that provides vaccines at no cost to children who might not otherwise be vaccinated because of their inability to pay, according to the CDC.

The CDC buys vaccine at a discounted rate for distribution to registered VFC providers. Children who are eligible* for VFC vaccines are entitled to receive those vaccines recommended by the Advisory Committee on Immunization Practices (ACIP).

The advisory committee voted 15-0, without objection.

On Thursday, the CDC’s Advisory Committee on Immunization Practices voted to recommend COVID-19 to be included in the 2023 childhood immunization schedule in 15 unanimous votes.

Pfizer mRNA Spike Protein Found in Deceased Man’s Brain and Heart: Peer-Reviewed Report

“We know it goes to the brain, it goes to the heart, it produces the spike protein, which damages those cells, causes inflammation… it travels… causing damage to blood vessels and blood clots.”

Authors: Kanekoa Kanekoa News October 6, 2022

Dr. Michael Mörz from the Institute for Pathology in Dresden, Germany, published a case study of an autopsy of a 76-year-old deceased man in the journal Vaccines.

In the report, spike proteins specifically attributed to COVID-19 vaccination targeted blood vessels in the man’s brain and heart.

Incredibly, the report used immunohistochemistry, which uses immune staining methods that light up specific antigens, to determine that “only spike protein but no nucleocapsid protein” could be detected meaning the necrotizing encephalitis (death of brain tissues) as well as the inflammatory changes in the small blood vessels (brain and heart) were caused by COVID-19 vaccination rather than viral infection.

“Surprisingly, only spike protein but no nucleocapsid protein could be detected within the foci of inflammation in both the brain and the heart, particularly in the endothelial cells of small blood vessels. Since no nucleocapsid protein could be detected, the presence of spike protein must be ascribed to vaccination rather than to viral infection. The findings corroborate previous reports of encephalitis and myocarditis caused by gene-based COVID-19 vaccines.”

Study: Nucleocapsid antibody positivity as a marker of past SARS-CoV-2 infection in population serosurveillance studies: impact of variant, vaccination, and choice of assay cut-off. Image Credit: Orpheus FX / Shutterstock
Since the COVID-19 vaccines only encode for the spike protein, but not the nucleocapsid found in natural infection, the autopsy doctor was able to determine that the heart and brain inflammation was caused by COVID-19 vaccination rather than natural infection.

Interestingly, the elderly man who had Parkinson’s Disease (PD) “experienced pronounced cardiovascular side effects, for which he repeatedly had to consult his doctor” after his first Astra Zeneca ChAdOx1 vector vaccine in May 2021.

After his second vaccination with Pfizer’s BNT162b2 mRNA vaccine in July 2021, the family noticed that the elderly man experienced “increased anxiety, lethargy, and social withdrawal.”

Furthermore, “there was a striking worsening of his PD symptoms, which led to severe motor impairment and a recurrent need for wheelchair support”, which the man “never fully recovered from” before receiving his third vaccination (second Pfizer) in December 2021.

Two weeks after the third vaccination, he “suddenly collapsed while eating dinner” without “coughing or any signs of food aspiration”.

He recovered from this more or less, but one week later, he again suddenly collapsed silently while eating his meal, leading to his hospitalization and death shortly thereafter.

The man’s family asked for an autopsy because he had already shown noticeable changes in behavior, cardiovascular symptoms, and worsening of his Parkinson’s Disease symptoms after each COVID-19 vaccination.

“In the brain, SARS-CoV-2 spike protein subunit 1 was detected in the endothelia, microglia, and astrocytes in the necrotic areas. Furthermore, spike protein could be demonstrated in the areas of lymphocytic periarteritis, present in the thoracic and abdominal aorta and iliac branches, as well as a cerebral basal artery. The SARS-CoV-2 subunit 1 was found in macrophages and in the cells of the vessel wall, in particular the endothelium. In contrast, the nucleocapsid protein of SARS-CoV-2 could not be detected in any of the corresponding tissue sections.”

Figure 10. Brain, Nucleus ruber. The abundant presence of SARS-CoV-2 spike protein in swollen endothelium of a capillary vessel shows acute signs of inflammation with sparse mononuclear inflammatory cell infiltrates (same vessel as shown in Figure 12, serial sections of 5 to 20 μm). Immunohistochemical demonstration for SARS-CoV-2 spike protein subunit 1 visible as brown granules in capillary endothelial cells (red arrow) and individual glial cells (blue arrow). Magnification: 200× Source: MDPI-Vaccine
Figure 12. Brain, Nucleus ruber. Negative immunohistochemical reaction for SARS-CoV-2 nucleocapsid protein. Cross section through a capillary vessel. Magnification: 200×. Source: MDPI-Vaccine
Figure 9. Frontal brain. Positive reaction for SARS-CoV-2 spike protein. Cross section through a capillary vessel (same vessel as shown in Figure 11, serial sections of 5 to 20 μm). Immunohistochemical reaction for SARS-CoV-2 spike subunit 1 detectable as brown granules in capillary endothelial cells (red arrow) and individual glial cells (blue arrow). Magnification: 200×. Source: MDPI-Vaccines
Figure 11. Frontal brain. Negative immunohistochemical reaction for SARS-CoV-2 nucleocapsid protein. Cross section through a capillary vessel (same vessel as shown in Figure 9, serial sections of 5 to 20 μm). Magnification: 200×. Source: MDPI-Vaccines

“Immunohistochemistry for SARS-CoV-2 antigens (spike protein and nucleocapsid) revealed that the lesions with necrotizing encephalitis as well as the acute inflammatory changes in the small blood vessels (brain and heart) were associated with abundant deposits of the spike protein SARS-CoV-2 subunit 1. Importantly, spike protein could be only demonstrated in the areas with acute inflammatory reactions (brain, heart, and small blood vessels), in particular in endothelial cells, microglia, and astrocytes. This is strongly suggestive that the spike protein may have played at least a contributing role to the development of the lesions and the course of the disease in this patient.”

Figure 13. Heart left ventricle. Positive reaction for SARS-CoV-2 spike protein. Cross section through a capillary vessel (same vessel as shown in Figure 14, serial sections of 5 to 20 μm). Immunohistochemical demonstration of SARS-CoV-2 spike subunit 1 as brown granules. Note the abundant presence of spike protein in capillary endothelial cells (red arrow) associated with prominent endothelial swelling and the presence of a few mononuclear inflammatory cells. Magnification: 400×. Source: MDPI-Vaccines
Figure 14. Heart left ventricle. Negative immunohistochemical reaction for SARS-CoV-2 nucleocapsid protein. Cross section through a capillary vessel (same vessel as shown in Figure 13, serial sections of 5 to 20 μm). Magnification: 400×. Source: MDPI-Vaccines

Dr. Robert Malone, a critic of the COVID-19 vaccination program, has long warned that the, “synthetic mRNA like genetic material persists in the body for 60 days or longer and produces spike protein at levels higher than is observed with the actual SARS-CoV-2 infection.”

Ominously, the CDC quietly removed the claim that the vaccine generated spike protein “does not last long in the body” from its website between July 16th and July 22nd.

“This is the first time we have had a vaccine go to the brain and go to the heart,” Dr. Peter McCullough, another expert has warned since last year.

“We know it goes to the brain, it goes to the heart, it produces the spike protein, which damages those cells, causes inflammation, and then from there it travels in the body causing damage to blood vessels and causing blood clots.”

Pfizer Exec Admits Under Oath: ‘We Never Tested COVID Vaccine Against Transmission’

A senior Pfizer executive has admitted under oath that the company never tested their Covid “vaccine” to see if it prevented transmission…

Authors: Jack Phillips reports via The Epoch Times, October 12, 2022

“Was the Pfizer COVID vaccine tested on stopping the transmission of the virus before it entered the market? Did we know about stopping immunization before it entered the market?”

Pfizer’s Janine Small, president of international developed markets, said in response:

“No … You know, we had to … really move at the speed of science to know what is taking place in the market.”

Roos, of the Netherlands, argued in a Twitter video Monday that following Small’s comments to him, millions of people around the world were duped by pharmaceutical companies and governments.

“Millions of people worldwide felt forced to get vaccinated because of the myth that ‘you do it for others,’” Roos said.

“Now, this turned out to be a cheap lie” and “should be exposed,” he added.

“If you don’t get vaccinated, you’re anti-social. This is what the Dutch Prime Minister and Health Minister told us,” Roos said.

“You don’t get vaccinated just for yourself, but also for others—you do it for all of society. That’s what they said.”

But that argument no longer holds, Roos explained.

“Today, this turns out to be complete nonsense. In a COVID hearing in the European Parliament, one of the Pfizer directors just admitted to me—at the time of introduction, the vaccine had never been tested on stopping the transmission of the virus.”

What Was Said

The Food and Drug Administration wrote in late 2020 that there was no data available to determine whether the vaccine would prevent transmission and for how long it would protect against transmission of the SARS-CoV-2 virus that causes COVID-19.

“At this time, data are not available to make a determination about how long the vaccine will provide protection, nor is there evidence that the vaccine prevents transmission of SARS-CoV-2 from person to person,” the agency specifically noted.

Meanwhile, Pfizer CEO Albert Bourla, around the same time, said his firm was “not certain” if those who receive its mRNA vaccine will be able to transmit COVID-19 to other people.

”I think this is something that needs to be examined. We are not certain about that right now,” Bourla told NBC News in December 2020 in response to a question about transmissibility.

Former White House medical adviser Dr. Deborah Birx in June revealed that there was evidence in December 2020 that individuals who received COVID-19 vaccines, including Pfizer’s, could still transmit the virus.

“We knew early on in January of 2021, in late December of 2020, that reinfection was occurring after natural infection,” Birx, the White House COVID-19 response coordinator during the Trump administration, told members of Congress this year.

‘Not Going to Get COVID’

A number of officials in the United States and around the world had claimed COVID-19 vaccines could prevent transmission. Among them, President Joe Biden in July 2021 remarked that “you’re not going to get COVID if you have these vaccinations.”

President Joe Biden speaks, flanked by White House Chief Medical Adviser on COVID-19 Dr. Anthony Fauci, during a visit to the National Institutes of Health in Bethesda, Md., on Feb. 11, 2021. (Saul Loeb/AFP via Getty Images)

Chief Biden administration medical adviser Anthony Fauci in May 2021 said in a CBS interview that vaccinated people are “dead ends” for COVID-19, suggesting they cannot transmit the virus.

“When you get vaccinated, you not only protect your own health and that of the family but also you contribute to the community health by preventing the spread of the virus throughout the community,” Fauci said.

Two months later, in late July of that year, Fauci said that vaccinated people are capable of transmitting the virus.

In the coming months, Fauci, Biden, CDC Director Dr. Rochelle Walensky, and others pivoted to say the vaccine prevents severe disease, hospitalization, and death from COVID-19.

At least one Twitter-er accepts responsibility… and hopefully learned from his un-erring ‘trust’…

UK Cardiologist: Pause the COVID Vaccine Program

Authors:  Michelle Edwards September 27, 2022 Nature Reports

One of Britain’s most influential cardiologists, Dr. Aseem Malhotra—citing a duty to his patients, scientific integrity, and the truth—just published what he describes as perhaps the most critical research paper of his prestigious career. His work, fueled by the sudden death of his “very fit and well” father in July 2021, critically appraised the real-world data around the mRNA COVID jab. After nine months of rigorous research and extensive peer review, Malhotra’s paper concludes what many heavily censored brave experts have been saying for months—the massive push to get the mRNA COVID-19 jab into the arms of humanity serves a purely sinister purpose: increased pharmaceutical shareholder profits at any cost. Indeed, with Pfizer in the lead, Malhotra is convinced the current system, which gives big pharma way too much power, is “encouraging good people to do bad things.” On that note, he is calling for all COVID-19 vaccines to be withdrawn. 

In conducting research for his paper titled ‘Curing the pandemic of misinformation on COVID-19 mRNA vaccines through real evidence-based medicine,’ Dr. Malhotra commented on the early headlines around the world making “very bold claims of 95% effectiveness” with the jabs. Likewise, he underscored the slippery way “efficacy” and “effectiveness” were used interchangeably to gloss over the significant difference between controlled trials and real-world conditions. Dr. Molhotra quickly realized the gaping holes in Pfizer’s mRNA clinical trials, noting he was alarmed to learn that there were four cardiac arrests in those who took the vaccine in the trial versus only one in the placebo group. He wrote:

“During early 2021, I was both surprised and concerned by a number of my vaccine-hesitant patients and people in my social network who were asking me to comment on what I regarded at the time as merely ‘anti-vax’ propaganda.

But a very unexpected and extremely harrowing personal tragedy was to happen a few months later that would be the start of my own journey into what would ultimately prove to be a revelatory and eye-opening experience so profound that after six months of critically appraising the data myself, speaking to eminent scientists involved in COVID-19 research, vaccine safety and development, and two investigative medical journalists, I have slowly and reluctantly concluded that contrary to my own initial dogmatic beliefs, Pfizer’s mRNA vaccine is far from being as safe and effective as we first thought.”

In January 2021, Dr. Malhotra, an NHS consultant, Fellow of the Royal College of Physicians, President of the Scientific Advisory Committee of The Public Health Collaboration, and internationally renowned expert in the prevention, diagnosis, and management of heart disease, was one of the first to receive the two-dose Pfizer jab. A firm believer in the “safe and highly effective” vaccines produced during the latter half of the 20th century, Dr. Malhotra states he got the mRNA shots mainly to “prevent transmission of the virus” to his vulnerable patients. In an appearance on Good Morning Britain, he even convinced “vaccine-hesitant” British film director Gurinder Chadha to take the jab.

Nevertheless, following his father’s sudden death, Malhotra was distraught after examining the post-mortem findings. Not long before his death, Malhotra had assessed his 73-year-old father’s heart and determined overall he was in excellent health. His dad, who also received the Pfizer mRNA jabs, walked 10 to 15,000 steps daily and was extremely conscientious of his diet. Yet, with no evidence of an actual heart attack, Malhotra couldn’t explain how his healthy father had two severe blockages in his coronary arteries, which caused his death. He explained:

“There were two severe blockages in his Corona arteries, which didn’t really make any sense with everything. I know [this] both as a cardiologist—someone who has expertise in this particular area—but also by intimately knowing my dad’s lifestyle and his health. 

Not long after that, data started to emerge [that] suggested a possible link between the mRNA vaccine and increased risk of heart attacks from a mechanism of increasing inflammation around the coronary arteries. But on top of that, I was then contacted by a whistleblower at a very prestigious university in the UK. A cardiologist himself, he explained to me that there was similar research findings in his department—and that those researchers have decided to essentially cover it up because they were worried about losing research funding from the pharmaceutical industry.” 

Presently, the sinister, big-pharma profit-driven, tyrannical, Great Reset reality in which we live is unmistakable to many. Still, to have Dr. Malhotra come forward in such a tremendous way indicates the voice of logic and reason is gaining momentum and getting louder. While talk of Sudden Adult Death Syndrome (SADS) and the myriad of sudden deaths we witness daily might yet fool some, many more are becoming increasingly aware of the fraudulent scheme at hand. Pointing to a burgeoning list of adverse events and the long-term uncertainty of vaccine-induced myocarditis, Malhotra’s paper calls out the crooked big pharma business model being employed by the global elite to coerce the world into being injected with the mRNA COVID jab. Published in the Journal of Insulin Resistance, it is well worth reading Dr. Malhotra’s two-part paper in full (here), and watching his Sept. 27 interview with the World Council for Health (here). Meanwhile, with his eyes wide open, in a recent interview, Malhotra conveyed a message he believes every human being needs to hear, declaring:

“[People] need to understand that the current system is encouraging good people to do bad things. At the root of this problem are big, very powerful corporations that have too much influence on government, on healthcare, and on media. And their primary responsibility is to produce profit for their shareholders, not to give you the best treatment. And when you understand that, then we can start doing something to transform the system.

And I don’t say this lightly. It has been well documented that these corporations, unfortunately, in how they go about their business, by misleading people, by their business model being fraudulent, they act like psychopaths—they are a psychopathic entity. Ultimately the conclusion is that we have a psychopathic entity influencing health policy, and that needs to stop—and it needs to stop now.”

Israeli Investigators Find COVID-19 Vaccines Cause Side Effects

Authors: by Meiling Lee and Zachary Stieber via The Epoch Times

Israeli researchers found some side effects that occurred after COVID-19 vaccination were caused by Pfizer’s vaccine, according to a leaked video.

The Israeli Ministry of Health (MoH) commissioned researchers to analyze adverse event reports submitted by Israelis and the researchers presented findings from the new surveillance system in an internal June 2022 meeting, video of which was obtained by an Israeli journalist.

Researchers said that the phenomenon of rechallenge—when adverse events reoccur or worsen following additional vaccine doses—proved that some of the events were caused by the vaccine.

A positive rechallenge was reported in 10 percent of the women who complained of menstrual issues, according to the researchers, who also identified cases of rechallenge for other adverse events.

Rechallenge changes a causal link “from possible to definitive,” Dr. Mati Berkovitch, head of the research team and a pediatric specialist, said at the meeting.

Rechallenge “helps us to establish the causal relationship,” added Sasha Zhurat, the main presenter at the meeting. The advantage of the surveillance system and the analysis “is not only to identify the symptoms but also to link them to the vaccine,” she said.

Footage of the meeting was leaked to Yaffa Shir-Raz, a health journalist and a risk communication researcher. Shir-Raz has publicly released clips from the meeting. The Epoch Times reviewed footage of the entire meeting and had key portions translated independently for this story.

About two months after the meeting, the MoH published a public report on the results of the data analysis. Language in the report on causality differed from that used during the meeting.

The report presents all the cases that were reported in close proximity to the receipt of the coronavirus vaccine, and does not necessarily indicate a causal relationship between receiving the vaccine and the reported phenomenon,” MoH said in the report.

MoH spokespersons did not return or declined to answer questions on the discrepancy. Instead, a spokesperson sent a press release dated Sept. 19, 2021, that announced the “establishment of a dedicated information headquarters for the fight against the coronavirus.”

Zhurat declined to comment.

“I’m no longer part of the project. Unfortunately, I cannot address your questions. Please reffer [sic] your queries to the MOH,” she told The Epoch Times via Facebook message.

A request for comment to Dr. Emilia Anis, director of the MoH Division of Epidemiology and a meeting attendee, was returned by the MoH, which declined to answer the questions asked of Anis.

Berkowitz did not respond to a request for comment.

Rechallenge

Rechallenge in pharmacovigilance is one of the factors to determine causality and refers to the re-administration of the same vaccine or drug after an adverse event goes away to examine whether the same event occurs again.

Dr. Robert Malone, who helped develop the messenger RNA (mRNA) technology on which Pfizer’s vaccine is built, told The Epoch Times that rechallenge is a “standard pharmaceutical clinical trial practice” that can provide definitive proof of causality.

The reports of rechallenge in the Israeli study do not prove causality,” according to Malone. Only a formal rechallenge trial would, he said. The analysis, though, “strongly suggests and supports causality,” he said.

Dr. Harvey Risch, a professor emeritus of epidemiology at the Yale School of Public Health, told The Epoch Times via email that the researchers “are essentially correct” in their conclusions that the vaccines caused the adverse events.

Researchers in other countries have said before that there are causal links between certain vaccines and certain side effects.

The current evidence supports a causal association between mRNA COVID-19 vaccination and myocarditis and pericarditis,” Dr. Tom Shimabukuro, a health researcher with the U.S. Centers for Disease Control and Prevention (CDC), said during a meeting over the summer.

Moderna’s COVID-19 vaccine also utilizes mRNA technology. Myocarditis and pericarditis are two forms of heart inflammation that can lead to death.

Most side effects following COVID-19 vaccination tend to be mild and typically last only a few days, according to the CDC. Other post-vaccination conditions are described as adverse events.

Side effects are health issues that have been proven to be caused by a vaccine, while an adverse event is a medical condition that may or may not be related to the vaccine.

The CDC’s Immunization Safety Office declined to comment on the Israeli findings. “CDC continues to monitor the safety of COVID-19 vaccines and makes information available to the public in a timely and transparent manner,” it told The Epoch Times via email.

Pfizer and Moderna have not responded to requests for comment.

Israel has primarily administered Pfizer’s vaccine, entering into a unique agreement (pdf) with the U.S.-based pharmaceutical company. Israel quickly received Pfizer doses. In return, the country allowed Pfizer executives to access some national health data.

Other Findings Not Made Public

Israel’s surveillance system was revamped in December 2021.

The data presented in June was collected from December 2021 to May.

The surveillance system received a total of 8,000 reports, of which 1,741 were removed for providing incomplete or duplicate information.

Of the 6,259 reports presented, 599 were for children aged 5 to 11; 299 for adolescents aged 12 to 17; and 5,411 for adults 18 and older. More women than men completed the questionnaire.

A total of 29 categories of adverse events were identified, 22 of them from the blank space option on the questionnaire. However, only data for the first five categories with the most reports were analyzed: neurological (395 reports), general side effects (295), menstrual disorder (282), musculoskeletal disorders (279), and the digestive, kidney, and urinary system (192).

Many of the reported adverse events were found to be long-lasting, which researchers said in the meeting was surprising since the brochure handed to vaccine recipients says otherwise. They also said Pfizer officials told them that Pfizer did not know of any long-lasting symptoms.

Researchers also said that they identified new adverse events not listed in the brochure, including back pain.

In the official report later issued to the public, the MoH did not detail how researchers were caught off guard by the duration of the events and side effects. The health agency also stated that there were no new events identified.

“In conclusion, the reported phenomena are known phenomena in the professional literature and were also found in the previous reports of the Ministry of Health, and there was no observation of an increase in a new phenomenon (new signal),” the MoH wrote.

Shir-Raz, the journalist who broke the story about the internal meeting, said the delay in reporting the results included not sharing the data with the MoH expert panel that convened near the end of June to decide whether to recommend Pfizer’s vaccine for children aged 6 months to 5 years.

“We have the protocol of this meeting, so we know it specifies which documents were presented to them when they made their decision, and there was no mention of this study in the protocol,” Shir-Raz told The Epoch Times, citing a MoH document (pdf) she obtained. “So they hid it even from their own experts.”

Shir-Raz who was fired from her job last year for writing articles critical of the MoH’s handling of the lockdown and COVID-19 deaths statistics, said that breaking the story was about “getting the truth out.”

“For the past two months, I’ve been dedicating myself almost entirely to this story only … It’s not just another issue for me, it’s not another article,” Shir-Raz said. “For me, it’s getting the truth out. Because it’s not just local … It has international implications.”

US Connection

Israel has often been the first country to report on vaccine safety and effectiveness. Its data has regularly been cited by U.S. agencies, including the CDC.

Dr. Sharon Alroy-Preis, an Israeli official who has said she’s in charge of vaccine safety monitoring, has presented data four times to the CDC and the U.S. Food and Drug Administration since September 2021, most recently in April 2022.

Pfizer Vaccine Whistleblower Responds To Motion To Dismiss False Claims Suit

Authors: Alex Giordano via The Epoch Times AUG 27, 2022 

Pfizer cannot use the government as a shield from liability for making false claims about its COVID-19 vaccine, lawyers for a whistleblower argued in response to Pfizer’s motion to dismiss a False Claims Act lawsuit.

Respondents claim fraudulent certifications, false statements, doctored data, contaminated clinical trials, and firing of whistleblowers can be ignored based on the theory that they contracted their way around the fraud,” lawyers for Brook Jackson, who worked as regional director at one of the clinical trials used to develop the Pfizer vaccine, wrote in their Aug. 22 response.

“A drug company cannot induce the taxpayers to pay billions of dollars for a product,” they countered, “that honest data would show poses more risks than benefits, and that ignores the actual contract and the law itself.”

Jackson’s lawsuit alleges that Pfizer and two of its subcontractors violated the False Claims Act by providing bogus clinical trial results to garner the FDA approval of its COVID-19 vaccine.

Under federal law, individuals can sue on behalf of the government and win treble damages if they can prove an individual or company deliberately lied to the government.

One of Jackson’s attorneys, Warner Mendenhall, told The Epoch Times that the payout could be as much as $3.3 trillion.

It would be enough to bankrupt Pfizer,” Mendenhall said.

Mendenhall, whose law firm has won multimillion-dollar False Claims Act cases, based his estimates on the more than $2 billion the U.S. government has paid Pfizer for more than 100 million doses of its COVID-19 vaccine.

In motions to dismiss the lawsuit, Pfizer and its subcontractors argued that besides Jackson’s allegations being false, the government, not a private citizen, can initiate a False Claims Act complaint and that the lawsuit against them should, therefore, be dismissed.

“The Relator may not pursue the claims against Pfizer without the Government first pursuing them in an administrative proceeding,” Pfizer’s motion states.

The companies also argued that the FDA was well aware of Jackson’s claims for at least two years before the lawsuit was filed against them and that it publicly responded to Jackson’s allegations by expressing the agency’s “full confidence” in the data used to support the vaccine.

However, Mendenhall said a false claims action is independent of the government’s knowledge and that Jackson only has to prove Pfizer and its subcontractors presented fraudulent information to the FDA.

Jackson was third in command of the clinical trials conducted by Ventavia Research Group as part of Pfizer’s application for emergency use authorization of its COVID-19 vaccine. She was there for only 18 days before being fired by Ventavia after reporting what she called “absolute mayhem” and an utter disregard for safety protocols and federal regulations in developing the vaccine.

Jackson has submitted over 400 exhibits as part of her complaint. Jackson said that a former Taco’s cashier was among those tasked with injecting patients with the experimental jab. She alleged that the trial staff falsified patient signatures on informed consent paperwork. And she has described a daily mess of unsanitary conditions.

Jackson also responded for the first time to Pfizer’s characterization of her as an anti-vaccine, anti-government individual out for money as vengeance for her firing.

Jackson has worked on a long list of government-run clinical trials for vaccines and said she is pro-vaccine. She pointed out that her children have had all their childhood vaccines and that her entire family gets the flu vaccine yearly. Jackson received the COVID-19 vaccine as soon as it was available and was initially one of its biggest cheerleaders.

While she is seeking compensation for her termination as part of her actions against Pfizer and the other companies, Jackson said she plans to donate any money she receives under her legal action against the companies to those injured by the vaccine.

As far as I’m concerned, it’s blood money,” she said. “The world should be disgusted by what went on here with the shameful actions behind this dangerous vaccine.”

Omicron’s Mutations Impaired Vaccine Effectiveness, CDC Says

Authors: Madison Muller  August 25, 2022 Bloomberg

Almost 40% of people hospitalized in the US with the Covid subvariant that circulated this spring were vaccinated and boosted, highlighting how new strains have mutated to more readily escape the immunity offered by current shots.

The findings from scientists at the US Centers for Disease Control and Prevention underscore the importance of having Covid shots that are better at targeting omicron subvariants. 

From the end of March through May, when the omicron BA.2 and BA.2.12.1 subvariants were dominant in the US, weekly hospitalization rates increased for all adults — with those over 65 hit the hardest. Even so, the total number of hospitalizations remained much lower than when the delta variant was rampant last fall. 

The overall number of hospitalizations is an important point, said Abraar Karan, an infectious disease doctor at Stanford University.

“When you look at who’s hospitalized, it’s much more likely that they will have been vaccinated because so many people are vaccinated now,” Karan said. “The real comparison is how many hospitalizations do we have now versus in the past when people were not vaccinated or not up-to-date with boosters.”

CDC scientists found that vaccines and boosters did a better job of keeping people with delta infections out of the hospital than those with later variants. Effectiveness decreased slightly with the BA.1 variant, then changed significantly with BA.2 — with a much greater share of hospitalized adults who had been vaccinated with at least one booster. 

Read more: Retiring Fauci expected Covid to be ‘behind us’

Immunity from vaccines starts to wane within six months, so staying up-to-date with shots is key to being fully protected. Fewer than half of Americans have gotten a booster shot.

Adults with at least two booster shots fared better than other people when BA.2 was dominant. The majority of those admitted to the hospital also had at least one underlying condition. Unvaccinated adults were more than three times as likely to be hospitalized, but breakthrough infections still represented a significant number of the severe Covid cases, the data show.

US regulators have pushed Moderna Inc., Pfizer Inc. and BioNTech SE to expedite development of omicron-specific boosters for a September rollout. The drugmakers this week submitted early data to the US Food and Drug Administration seeking emergency clearance for updated shots that target the BA.4 and BA.5 virus strains. Scientists and vaccinemakers are already beginning to look toward next-generation shots that may provide longer-lasting protection against more variants. 

The new report’s findings also indicate that along with vaccination, other pharmaceutical and non-pharmaceutical measures should be used by those at highest risk of getting Covid. That includes easy access to therapeutics such as Pfizer’s antiviral drug Paxlovid and Gilead Sciences’ remdesivir, as well as AstraZeneca’s Evusheld for immunocompromised people. Scientists also note that wearing a mask can help guard the wearer from getting sick.  

Though the number of Covid deaths is the lowest it has been since last July, the US continues to see hundreds of deaths each day from Covid, CDC data show.

Vascular and organ damage induced by mRNA vaccines: irrefutable proof of causality

Authors: Michael Palmer, MD and Sucharit Bhakdi, MD August 19, 2022 Popular Science

This article summarizes evidence from experimental studies and from autopsies of patients deceased after vaccination. The collective findings demonstrate that

  1. mRNA vaccines don’t stay at the injection site by instead travel throughout the body and accumulate in various organs,
  2. mRNA-based COVID vaccines induce long-lasting expression of the SARS-CoV-2 spike protein in many organs,
  3. vaccine-induced expression of the spike protein induces autoimmune-like inflammation,
  4. vaccine-induced inflammation can cause grave organ damage, especially in vessels, sometimes with deadly outcome.

We note that the damage mechanism is which emerges from the autopsy studies is not limited to COVID-19 vaccines only but is completely general—it must be expected to occur similarly with mRNA vaccines against any and all infectious pathogens. This technology has failed and must be abandoned.

While clinical case reports (e.g. [1,2]) and statistical analyses of accumulated adverse event reports (e.g. [3,4]) provide valuable evidence of damage induced by mRNA-based COVID-19 vaccines, it is important to establish a causal relationship in individual cases. Pathology remains the gold standard for proof of disease causation. This short paper will discuss some key findings on autopsy materials from patients who died within days to several months after vaccination. For context, some experimental studies are briefly discussed as well.

1. Most of the evidence presented here is from the work of pathologist Prof. Arne Burkhardt, MD

  • Dr. Burkhardt was approached by the families of patients deceased after “vaccination”
  • Autopsy materials were examined by standard histopathology and immunohistochemistry
  • Based on the findings, most deaths were attributed to “vaccination” with a high to very high degree of likelihood

Prof. Burkhardt is a very experienced pathologist from Reutlingen, Germany. With the help of his colleague Prof. Walter Lang, he has studied numerous cases of death which occurred within days to several months after vaccination. In each of these cases, the cause of death had been certified as “natural” or “unknown.” Burkhardt became involved only because the bereaved families doubted these verdicts and sought a second opinion. It is remarkable, therefore, that Burkhardt found not just a few but the majority of these deaths to be due to vaccination.

While all four major manufacturers of gene-based vaccines were represented in the sample of patients studied by Burkhardt and Lang, most patients had received an mRNA vaccine from either Pfizer or Moderna. Some of the deceased patients had received both mRNA- and viral vector-based vaccines on separate occasions.

2. Pfizer’s own animal experiments show that the vaccine quickly distributes throughout the body

In order to cause potentially lethal damage, the mRNA vaccines must first distribute from the injection site to other organs. That such distribution occurs is apparent from animal experiments reported by Pfizer to Japanese authorities with its application for vaccine approval in that country [5]. Rats were injected intramuscularly with a radioactively labelled model mRNA vaccine, and the movement of the radiolabel first into the bloodstream and subsequently into various organs was followed for up to 48 hours.

The first thing to note is that the labelled vaccine shows up in the blood plasma after a very short time—within only a quarter of an hour. The plasma level peaks two hours after the injection. As it drops off, the model vaccine accumulates in several other organs. The fastest and highest rise is observed in the liver and the spleen. Very high uptake is also observed with the ovaries and the adrenal glands. Other organs (including the testes) take up significantly lower levels of the model vaccine. We note, however, that at least the blood vessels will be exposed and affected in every organ and in every tissue.

The rapid and widespread distribution of the model vaccine implies that we must expect expression of the spike protein throughout the body. For a more in-depth discussion of this biodistribution study, see Palmer2021b.

3. Expression of viral proteins can be detected with immunohistochemistry

While the distribution of the model vaccine leads us to expect widespread expression of the spike protein, we are here after solid proof. Such proof can be obtained using immunohistochemistry, which method is illustrated in this slide for the vaccine-encoded spike protein.

If a vaccine particle—composed of the spike-encoding mRNA, coated with lipids—enters a body cell, this will cause the spike protein to be synthesized within the cell and then taken to the cell surface. There, it can be recognized by a spike-specific antibody. After washing the tissue specimen to remove unbound antibody molecules, the bound ones can be detected with a secondary antibody that is coupled with some enzyme, often horseradish peroxidase. After another washing step, the specimen is incubated with a water-soluble precursor dye that is converted by the enzyme to an insoluble brown pigment. Each enzyme molecule can rapidly convert a large number of dye molecules, which greatly amplifies the signal.

At the top right of the image, you can see two cells which were exposed to the Pfizer vaccine and then subjected to the protocol outlined above. The intense brown stain indicates that the cells were indeed producing the spike protein.

In short, wherever the brown pigment is deposited, the original antigen—in this example, the spike protein—must have been present. Immunohistochemistry is widely used not only in clinical pathology but also in research; it could readily have been used to detect widespread expression of spike protein in animal trials during preclinical development. However, it appears that the FDA and other regulators never received or demanded such experimental data [6].

4. Expression of spike protein in shoulder muscle after vaccine injection

This slide (by Dr. Burkhardt) shows deltoid muscle fibres in cross section. Several (but not all) of the fibres show strong brown pigmentation, again indicating spike protein expression.

While the expression of spike protein near the injection site is of course expected and highly suggestive, we would like to make certain that such expression is indeed caused by the vaccine and not by a concomitant infection with the SARS-CoV-2 virus. This is particularly important with respect to other tissues and organs which are located far away from the injection site.

5. Coronavirus particles contain two prominent proteins: spike (S) and nucleocapsid (N)

To distinguish between infection and injection, we can again use immunohistochemistry, but this time apply it to another SARS-CoV-2 protein—namely, the nucleocapsid, which is found inside the virus particle, where it enwraps and protects the RNA genome. The rationale of this experiment is simple: cells infected with the virus will express all viral proteins, including the spike and the nucleocapsid. In contrast, the mRNA-based COVID vaccines (as well as the adenovirus vector-based ones produced by AstraZeneca and Janssen) will induce expression only of spike.

6. Infected persons express the nucleocapsid protein (and also the spike protein)

This slide simply illustrates that the method works: lung tissue or cells from a nasal swab of a person infected with SARS-CoV-2 stain positive for nucleocapsid expression, whereas cultured cells exposed to the vaccine do not (but they stain strongly positive for the spike protein; see inset at the top right of Slide 3).

7. Injected persons express only the spike protein, which implicates the vaccine

Here, we see immunohistochemistry applied to heart muscle tissue from an injected person. Staining for the presence of spike protein causes strong brown pigment deposition. In contrast, only very weak, non-specific staining is observed with the antibody that recognizes the nucleocapsid protein. The absence of nucleocapsid indicates that the expression of the spike protein must be attributed ot the vaccine rather than an infection with SARS-CoV-2.

We will see shortly that the strong expression of spike protein in heart muscle after vaccination correlates with significant inflammation and tissue destruction.

8. Expression of spike protein within the walls of small blood vessels

We see spike protein expression in arterioles (small arteries; left) as well as in venules (small veins) and capillaries (right). Expression is most prominent in the innermost cell layer, the endothelium. This makes the endothelial cells “sitting ducks” for an attack by the immune system.

9. Endothelial stripping and destruction of a small blood vessel after vaccination

We now turn to the evidence of immune attack on the endothelial cells which produce the spike protein. On the left, a normal venule, delimited by an intact endothelium and containing some red blood cells and few white blood cells (stained blue) inside.

The image on at the centre shows a venule that is being attacked and destroyed by the immune system. The outline is already dissolving, and the spindle-shaped (and swollen) endothelial cells have peeled off from the vessel wall. Furthermore, we see lymphocytes—the small cells with dark, round nuclei and with very little cytoplasm around them; a single lymphocyte (at much higher magnification) is shown on the right.

Lymphocytes are the backbone of the specific immune system—whenever antigens are recognized and antibodies are produced, this is done by lymphocytes. Also among the lymphocytes we find cytotoxic T cells and natural killer cells, which serve to kill virus-infected cells—or ones that look to them as if infected, because they have been forced to produce a viral protein by a so-called vaccine.

A crucial function of the endothelium is to prevent blood clotting. Thus, if the endothelium is damaged, as it is in this picture, and the tissues beyond it make contact with the blood, this will automatically set off blood clotting.

10. A crack in the wall of the aorta, lined by clusters of lymphocytes, leading to aortic rupture

On the left, a section through the wall of an aorta. This picture is taken at an even lower magnification than the one before; the lymphocytes now appear as just a cloud of tiny blue specks. To the left of this blue cloud, we see a vertical crack running through the tissue. Such a crack is also visible macroscopically in the excised specimen of an aorta shown on the right.

The aorta is the largest blood vessel of the body. It receives the highly pressurized blood ejected by the left ventricle of the heart, and it is thus exposed to intense mechanical stress. If the wall of the aorta is weakened by inflammation, as it is here, then it may crack and rupture. Aortic rupture is normally quite rare, but Prof. Burkhardt found multiple cases in his limited number of autopsies. Some of the affected aortas were also shown to have expressed the spike protein.

11. Healthy heart muscle tissue, and lymphocytic myocarditis

In Slide 7, we saw that heart muscle cells strongly expressed the spike protein after vaccine injection. Here, we see the consequences. The picture on the shows a sample of healthy heart muscle tissue, with regularly oriented and aligned heart muscle fibres. On the right, we see a heart muscle sample from one of the autopsies. The muscle fibres are disjointed and disintegrating, and they are surrounded by invading lymphocytes. Burkhardt found myocarditis in multiple of his deceased patients.

12. Lymphocytic infiltration and proliferative inflammation in lung tissue

On the left, we see healthy lung tissue, with air-filled spaces (the alveoli), delimited by delicate alveolar septa with embedded, blood-filled capillaries. We also see some larger blood vessels.

On the right hand side, we see lung tissue overrun by lymphocytes. The air-filled spaces have largely disappeared and been filled with scar (connective) tissue. This vaccine-injected patient would obviously have had very great trouble breathing.

Lymphocytic infiltration, inflammation and destruction were also observed in many other organs, including the brain, the liver, the spleen, and multiple glands. However, instead of illustrating them all, we will conclude the pathological evidence with another immunohistochemistry result, which strikingly shows the long duration of spike protein expression.

13. Vaccine-induced expression of spike protein in a bronchial biopsy nine months after vaccination

The slide shows a sample of bronchial mucous membrane, from a patient who is alive but has suffered respiratory symptoms ever since being vaccinated. We see several cells in the uppermost cell layer that strongly express spike protein—and this even nine months after his most recent vaccine injection! While this is indeed the most extreme case of long-lasting expression, there is evidence both from Burkhardt’s autopsies and from published studies on blood samples [7] or lymph node biopsies [8] to indicate that expression does last several months.

14. The Pfizer vaccine mRNA gets copied (“reverse-transcribed”) into DNA and inserted into the cellular genome

The official mRNA vaccine narrative maintains that the modified mRNA contained in the vaccine will not be replicated in vivo; expression of the spike protein should therefore cease once the injected RNA molecules have been degraded.

The limited experimental studies available [9,10] suggest that the injected modified mRNA should be degraded within days to a few weeks of the injection. This is obviously difficult to square with the observed long-lasting expression; in some form or other, the genetic information appears to be perpetuated in vivo.

A recent experimental study from Sweden [11] has shown that human-derived cells can copy the Pfizer mRNA vaccine into DNA and then insert it into their own chromosomal DNA. The image shows the key evidence from this study. The cells were exposed to the vaccine for the lengths of time indicated. Cellular DNA was then isolated, and inserted DNA copies of the vaccine mRNA detected by PCR amplification of a fragment 444 base pairs (bp) in length.

All samples labelled with “BNT” had been treated with the vaccine, and they all show a PCR product of the expected length, as is evident from comparison to a DNA fragment length standard (“L”). Samples labelled with “Ctrl n” were controls: Ctrl 1– 4 contained DNA from cells not incubated with vaccine, Ctrl 5 contained RNA (not DNA) from vaccine-treated cells; Ctrl 6 contained the same but was additionally treated with RNAse, which step was also performed in the purification of DNA samples. As expected, none of the control samples contain the PCR product.

Considering Aldén’s observation of DNA insertion in every single experimental sample, it seems highly likely that this will also occur in vivo. Beyond providing a plausible mechanism for perpetuating the expression of spike protein, DNA insertion also poses risks of genetic damage, leading to cancers and leukemias.

15. Summary

The evidence presented here clearly demonstrates a chain of causation from vaccine injection to

  • rapid distribution of the vaccine through the bloodstream,
  • widespread spike protein expression, prominently in blood vessels, and
  • autoimmune-like inflammation and organ damage.

Vaccine-induced vascular damage will promote blood clotting, and clotting-related diseases such as heart attack, stroke, lung embolism are very common in the adverse events databases [4,12].

In addition to autoimmune-like inflammation, other disease mechanisms, including prion-mediated CNS degeneration [13], aberrant vascular protein deposition (amyloidosis) [14,15], and lipid nanoparticle toxicity [16], are plausible but require further study and corroboration. Overall, these vaccines can no longer be considered experimental—the “experiment” has resulted in the disaster that many medical doctors and scientists predicted from the outset [17]. The vaccination must be stopped, and all approvals and authorizations of their use must be revoked.

References

  1. Bozkurt, B. et al. (2021) Myocarditis With COVID-19 mRNA Vaccines. Circulation 144:471-484
  2. Ehrlich, P. et al. (2021) Biopsy-proven lymphocytic myocarditis following first mRNA COVID-19 vaccination in a 40-year-old male: case report. Clinical research in cardiology official journal of the German Cardiac Society 110:1855-1859
  3. Rose, J. and McCullough, P.A. (2021) A Report on Myocarditis Adverse Events in the U.S. Vaccine Adverse Events Reporting System (VAERS) in Association with COVID-19 Injectable Biological Products. Current problems in cardiology p. 101011
  4. Shilhavy, B. (2022) 43,898 Dead, 4,190,493 Injured Following COVID Vaccines in European Database of Adverse Reactions.
  5. Anonymous, (2020) SARS-CoV-2 mRNA Vaccine (BNT162, PF-07302048) 2.6.4 Summary statement of the pharmacokinetic study [English translation].
  6. Latyopva, A. (2022) Did Pfizer Perform Adequate Safety Testing for its Covid-19 mRNA Vaccine in Preclinical Studies? Evidence of Scientific and Regulatory Fraud.
  7. Bansal, S. et al. (2021) Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines. J. Immunol. 207:2405-2410
  8. Röltgen, K. et al. (2022) Immune imprinting, breadth of variant recognition and germinal center response in human SARS-CoV-2 infection and vaccination. Cell (preprint)
  9. Andries, O. et al. (2015) N1-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice. J. Control. Release 217:337-344
  10. Pardi, N. et al. (2018) Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses. J. Exp. Med. 215:1571-1588
  11. Aldén, M. et al. (2022) Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line. Curr. Issues Mol. Biol. 44:1115-1126
  12. Anonymous, (2021) OpenVAERS.
  13. Perez, J.C. et al. (2022) Towards the emergence of a new form of the neurodegenerative Creutzfeldt-Jakob disease: Twenty six cases of CJD declared a few days after a COVID-19 “vaccine” Jab. ResearchGate (preprint)
  14. Charnley, M. et al. (2022) Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19. Nat. Commun. 13:3387
  15. Nyström, S. and Hammarström, P. (2022) Amyloidogenesis of SARS-CoV-2 Spike Protein. J. Am. Chem. Soc. 144:8945-8950
  16. Palmer, M. and Bhakdi, S. (2021) The Pfizer mRNA vaccine: Pharmacokinetics and Toxicity.
  17. Bhakdi, S. et al. (2021) Urgent Open Letter from Doctors and Scientists to the European Medicines Agency regarding COVID-19 Vaccine Safety Concerns.